The implementation of intravenous tissue plasminogen activator in acute ischaemic stroke - A scientific position statement from the National Stroke foundation and the Stroke Society of Australasia

Internal Medicine Journal

Volumn 39, Issue 5, 2009, Pages 317-324

  Levi, Christopher ^a   Lindley, Richard ^a   Smith, Brendon ^a   Bladin, Christopher ^a   Parsons, Mark ^a   Read, Stephen ^a   Cadilhac, Dominique ^a   Donnan, Geoffrey ^a   Davis, Stephen ^a   Hankey, Graeme ^a   Crimmins, Dennis ^a   Gerraty, Richard ^a   Blacker, David ^a   Schultz, David ^a   Grimley, Rohan ^a   Lalor, Erin ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Acute management; Cerebrovascular disease; Stroke; Thrombolysis

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; PLACEBO; SARUPLASE; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

AUSTRALIA; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; CLINICAL TRIAL; CONSENSUS; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EMERGENCY CARE; EMERGENCY MEDICINE; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HUMAN; MEDICAL SOCIETY; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; REVIEW;

EID: 67650917363     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2009.01938.x     Document Type: Review

References (34)

1. National Stroke Foundation. Clinical Guidelines for Acute Stroke Management. Melbourne : NSF 2007.
2. Stroke Unit Trialists' Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev 2007 4 : CD000197. DOI: 101002/14651858CD000197pub2
3. Gilligan AK, Thrift AG, Sturm JW, Dewey HM, Macdonell RA, Donnan GA et al. Stroke and neuroprotection: which stroke intervention could provide the greatest community benefit?. Cerebrovasc Dis 2005 20 : 239 44.
4. The ATLANTIS, ECASS and NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS and NINDS rt-PA Stroke Trials. Lancet 2004 363 : 768 74.
5. National Stroke Foundation. National Stroke Audit - Clinical Report Acute Services. Melbourne : NSF 2007.
6. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008 359 : 1317 29.
7. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995 333 : 1581 7.
8. Mann J. Truths about the NINDS study. Setting the record straight. West J Med 2002 176 : 192 4.
9. Trotter G. Why were the benefits of tPA exaggerated?. West J Med 2002 176 : 194 7.
10. Marler JR, Tilley BC, Lu M, Brott TG, Lyden PC, Grotta JC et al. Early stroke treatment associated with better outcome. The NINDS rt-PA stroke study. Neurology 2000 55 : 1649 55.
11. Ingall TJ, O'Fallon WM, Asplund K, Goldfrank LR, Hertzberg VS, Louis TA et al. Findings from the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial. Stroke 2004 35 : 2418 24.
12. Wardlaw JM, del Zoppo G, Yamaguchi T, Berge E. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 2003, 3 : CD000213. DOI: 10.1002/14651858.CD000213
13. Graham GD. Tissue plasminogen activator for acute ischemic stroke in clinical practice: a meta-analysis of safety data. Stroke 2003 34 : 2847 50.
14. Hill MD, Buchan AM, for the Canadian Alteplase for Stroke Effectiveness Study (CASES) Investigators. Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ 2005 172 : 1307 12.
15. Katzan IL, Furlan AJ, Lloyd LE, Frank JI, Harper DL, Hinchey JA et al. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland Area Experience. JAMA 2000 283 : 1151 8.
16. Katzan IL, Hammer MD, Furlan AJ, Hixon ED, Nadzam DM et al. Quality improvement and tissue-type plasminogen activator for acute ischaemic stroke. A Cleveland update. Stroke 2003 34 : 799 800. (Pubitemid 36307415)
17. Wahlgren N, Ahmed N, Davalos A, Ford GA, Grond M, Hacke W et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007 369 : 275 82.
18. Schumacher HC, Bateman BT, Boden-Albala B, Berman MF, Mohr JP, Sacco RL et al. Use of thrombolysis in acute ischemic stroke: analysis of the Nationwide Inpatient Sample 1999 to 2004. Ann Emerg Med 2007 50 : 99 107. (Pubitemid 47079072)
19. Lindsay P, Bayley M, Hellings C, Hill M, Woodbury E, Phillips S Canadian best practice recommendations for stroke care (updated 2008). CMAJ 2008 179 (12 Suppl. E1 E93.
20. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008 25 : 457 507 cited 2008 Oct 1]. Available from: URL: at http://www.eso-stroke.org/pdf/ESO08-Guidelines-English.pdf
21. National Institute for Health and Clinical Excellence. Altepase for the Treatment of Acute Ischaemic Stroke (TA 122). London : NICE 2007 cited 2008 Oct 1]. Available from: URL: http://www.nice.org.uk/nicemedia/pdf/TA122guidance.pdf
22. Adams HP, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A et al. Guidelines for the Early Management of Patients with Ischemic Stroke. A scientific statement from the Stroke Council of the American Heart Association. Stroke 2007 38 : 1655 711. Epub 2007 Apr 12. Erratum in: Stroke 2007; 38: e96.
23. New Zealand Stroke Foundation. Life after stroke. New Zealand Guideline for management of stroke. November 2003.
24. Use of Intravenous tPA for the Management of Acute Stroke in the Emergency Department. Approved by the ACEP Board of Directors February 2002 cited 2008 Oct 1]. Available from: URL: http://www.acep.org/practres.aspx?id= 29834
25. Position Statement of the American Academy of Emergency Medicine on the Use of Intravenous Thrombolytic Therapy in the Treatment of Stroke. Submitted to AAEM by the Work Group on Thrombolytic Therapy in Stroke. Adopted 9 January 2002. [cited 2008 Oct 1]. Available from: URL: http://www.aaem.org/ positionstatements/thrombolytictherapy.shtml)
26. Canadian Association of Emergency Physicians Committee on Thrombolytic Therapy for Acute Ischemic Stroke. CAEP Position Statement. Thrombolytic therapy for acute ischemic stroke. CJEM 2001 3 cited 2008 Oct 1]. Available from: URL: http://www.caep.ca/template.asp?id=91b10eb5fbc84635aad8a7b0fb9f7aa0
27. Szoeke CE, Parsons MW, Butcher KS, Baird TA, Mitchell PJ, Fox SE et al. Acute stroke thrombolysis with intravenous tissue plasminogen activator in an Australian tertiary hospital. Med J Aust 2003 178 : 324 8.
28. Bray JE, Coughlan K, Bladin C. Thrombolytic therapy for acute ischaemic stroke: successful implementation in an Australian tertiary hospital. Intern Med J 2006 36 : 483 8.
29. Batmanian JJ, Lam M, Matthews C, Finckh A, Duffy M, Wright R et al. A protocol-driven model for the rapid initiation of stroke thrombolysis in the emergency department. Med J Aust 2007 187 : 567 70.
30. Schriger DL, Kalafut M, Starkman S, Krueger M, Saver JL. Cranial computed tomography interpretation in acute stroke: physician accuracy in determining eligibility for thrombolytic therapy. JAMA 1998 279 : 1293 7.
31. Libman RB, Wirkowski E, Alvir J, Rao H. Conditions that mimic stroke in the Emergency Department: implications for acute stroke trials. Arch Neurol 1995 52 : 1119 22.
32. Hand P, Kwan J, Lindley R, Dennis M, Wardlaw J. Distinguishing between stroke and mimic at the bedside. The brain attack study. Stroke 2006 37 : 769 75.
33. National Stroke Foundation. Acute Stroke Services Framework. Melbourne : National Stroke Foundation 2008. Available from: URL: http://www. strokefoundation.com.au
34. Bray JE, Martin J, Cooper G, Barger B, Bernard S, Bladin C. An interventional study to improve paramedic diagnosis of stroke. Prehosp Emerg Care 2005 9 : 297 302. (Pubitemid 43205572)